4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-052145
EVP & Chief Strategy Officer gave up 22,158 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Soffer Gad EVP & Chief Strategy Officer | 2018-09-22 | Shares withheld for taxes | −22,158 | $39.85 | $882,996 | 243,966 | D |
Loading xslF345X03/doc4.xml…